Core Viewpoint - GuanZe Medical (02427) is in discussions regarding the potential sale of 699 million shares, representing approximately 73.60% of its total issued share capital, by its controlling shareholder Meng A Capital Limited [1][2] Group 1 - The company's shares experienced a rise in price and trading volume on January 26, 2026, prompting the announcement [1] - Meng A Capital, which is wholly owned by the company's chairman and CEO Meng Xianzheng, currently holds 699 million shares, accounting for about 73.60% of the company's issued share capital [1] - The details of the potential sale, including the price, are still under negotiation, and no formal agreement has been established as of the announcement date [1][2] Group 2 - Upon completion of the potential sale, the prospective buyer and its concert parties are expected to hold over 50% of the company's issued share capital [2] - According to the Takeover Code, if the potential sale proceeds, the prospective buyer and its concert parties must make a mandatory unconditional general offer for all issued shares, excluding those already owned or agreed to be acquired [2] - The board has been informed that no formal agreement has been reached regarding the potential sale, and negotiations are ongoing [2]
GUANZE MEDICAL：股价及成交量异常波动 控股股东Meng A Capital有意出售公司约73.6%股份